Clinical Trial Update: Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating STEAP1-targeted CAR-T cell therapy in combination with enzalutamide for metastatic castration-resistant prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• STEAP1 CART

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING